Multiplex reverse transcription polymerase chain reaction screening in acute myeloid leukemia detects cytogenetically unrevealed abnormalities of prognostic significance

Marianne Hutchings Hoffmann, Tobias Wirenfeldt Klausen, Henrik Hasle, Kjeld Schmiegelow, Karen Brondum-Nielsen, Hans Erik Johnsen

11 Citationer (Scopus)

Abstract

A commercial multiplex reverse transcription polymerase chain reaction screening assay, covering 28 leukemic fusion transcripts, was applied in 143 samples obtained from patients with acute myeloid leukemia at primary diagnosis. In five patients, a cytogenetically unrevealed fusion gene of prognostic importance was detected, while the assay failed to detect one case of t(15;17).

OriginalsprogEngelsk
TidsskriftHaematologica
Vol/bind90
Udgave nummer7
Sider (fra-til)984-6
Antal sider3
ISSN0390-6078
StatusUdgivet - jul. 2005

Fingeraftryk

Dyk ned i forskningsemnerne om 'Multiplex reverse transcription polymerase chain reaction screening in acute myeloid leukemia detects cytogenetically unrevealed abnormalities of prognostic significance'. Sammen danner de et unikt fingeraftryk.

Citationsformater